Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 29, 2017

View Archived Issues

Engineered SIRPalpha-inhibited, marrow-derived macrophages engulf cancer cells in solid tumors

Plant-produced VLPs of the stabilized PV3 mutant SktSC8 as novel polio vaccine candidate

European Commission approves amendment to Minerva's agreement with Janssen for MIN-202

CANTOS results with canakinumab highlight effects of inflammation on heart attack, cancer risks

AKR1C3 inhibitor BAY-1128688 shows promise for the treatment of endometriosis

Biogen reports data from long-term extension of ongoing phase Ib trial of aducanumab

Gilead Sciences to acquire Kite Pharma

FDA approves expanded use of Faslodex monotherapy in breast cancer

Results presented for KHK inhibitor PF-06835919 for the treatment of NAFLD/NASH

FDA considers the NDA resubmission for Lutathera to be complete

European Commission approves Fotivda for advanced renal cell carcinoma

Bristol-Myers Squibb and Daiichi agree to study Opdivo with DS-8201 in breast and bladder cancers

FDA grants priority review to LJPC-501 NDA

Coherus reports findings from pharmacokinetic study of adalimumab biosimilar CHS-1420

Ophirex licenses sPLA2 inhibitor data from Lilly and Shionogi to support snakebite program

PureTech Health licenses Glyph technology from Monash University

Epizyme patents PRMT inhibitors

BioCryst Pharmaceuticals divulges complement factor D inhibitors

FDA steps up enforcement in area of stem cell therapy and regenerative medicine

EA Pharma discovers novel MAdCAM antagonists

Berg establishes research collaboration with AstraZeneca

New orexin receptor agonists presented by Takeda Pharmaceutical

Shionogi presents new NTRK1 inhibitors

Synlogic and Mirna Therapeutics complete merger

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld Science
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...